Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial

Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial

Abstract Background Septic shock is characterized by an uncontrolled inflammatory response and microcirculatory dysfunction. There is currently no specific agent for treating septic shock. Anisodamine is an agent extracted from traditional Chinese medicine with potent anti-inflammatory effects. Howe...

Full description

Bibliographic Details
Main Authors: Yuetian Yu, Cheng Zhu, Yucai Hong, Lin Chen, Zhiping Huang, Jiancang Zhou, Xin Tian, Dadong Liu, Bo Ren, Cao Zhang, Caibao Hu, Xinan Wang, Rui Yin, Yuan Gao, Zhongheng Zhang
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Critical Care
Subjects:
Septic shock
Anisodamine
Randomized controlled trial
Mortality
Mechanical ventilation
Online Access:https://doi.org/10.1186/s13054-021-03774-4

Internet

https://doi.org/10.1186/s13054-021-03774-4

Similar Items